• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19

Clinical trials

Axi-cel as an effective second-line treatment for R/R LBCL patients ineligible for transplanta...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Highlights in chronic lymphocytic leukaemia
  • Highlights in chronic myeloid leukaemia
  • Highlights in lymphoma
  • Long-term outcomes of isatuximab in high-risk multiple myeloma
  • Highlights in multiple myeloma
  • Navigating secondary acute myeloid leukaemia in 2023
  • Highlights in acute myeloid leukaemia and myelodysplastic syndromes
  • Highlights in acute lymphoblastic leukaemia
  • New haematology reimbursements in Belgium
Clinical trials

Reduced annualised bleeding rate in haemophilia patients receiving concizumab

Read more
CongressUpdate

Prognostic factors for maintenance of molecular remission after TKI discontinuation in CML pat...

Read more
Clinical trials

Dasatinib with intensive chemotherapy is safe and effective in paediatric Ph-positive ALL

Read more
Clinical trials

Efficacy of pirtobrutinib in CLL and SLL patients previously treated with covalent BTK inhibit...

Read more
Clinical trials

Gemtuzumab ozogamicin reduces the incidence of relapse in NPM1-mutated AML patients

Read more
Clinical trials

Promising efficacy and safety results of nipocalimab in high-risk HDFN patients

Read more
Clinical trials

Gut microbiome associated with clinical responses to CAR-T immunotherapy in lymphoma patients

Read more
Clinical trials

Immune effects of rituximab in children with high-risk B-cell non-Hodgkin lymphoma

Read more
1 2 3 4 5 6 7 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023